Loading
Sections

Skip to content. | Skip to navigation

Center for Infectious Diseases
Administrative Offices Only - No Patients Access

CB# 7030
130 Mason Farm Road
2nd Floor Bioinformatics
Chapel Hill, NC 27599
T: (919) 966-2536
F: (919) 966-6714

 

UNC Infectious Diseases Clinic
For Patient Services and Care

101 Manning Drive
1st Floor Memorial Bldg.
Chapel Hill, NC  27514
T: (919) 966-7198
F: (919) 966-4587

 

Web master:
cfid@unc.edu

 
You are here: Home > Research > HIV and STDs > The BAN Study

The BAN Study

BAN study group
BAN Study staff, Lilongwe, Malawi

 
The BAN study is a randomized, comparative clinical trial among HIV-infected women and their infants to determine the benefit of nutritional supplementation given to women during breastfeeding, the benefit and safety of antiretroviral medications given either to infants or to their mothers to prevent HIV transmission during breastfeeding and the feasibility of exclusive breastfeeding followed by early, rapid breastfeeding cessation.

Study sponsors and collaborators

Center for Infectious Diseases, University of North Carolina at Chapel Hill
U.S. Centers for Disease Control and Prevention
Kamuzu Central Hospital, Lilongwe, Malawi

Learn more
Breakthrough of the Year!

The HIV Prevention Trials Network 052 study, led by center director Myron S. Cohen, M.D., has been named the 2011 Breakthrough of the Year by the journal Science.